Alx Oncology Holdings, Inc. (ALXO) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alx Oncology Holdings, Inc. faces a significant risk due to its potential delisting from the Nasdaq Global Select Market, which could adversely affect its stock liquidity and price. The company has been notified by Nasdaq of non-compliance with the minimum bid price requirement, as its stock has closed below $1.00 per share for over 30 consecutive business days. This situation threatens Alx Oncology’s ability to raise additional funds and maintain investor confidence. If the company fails to regain compliance within the given 180-day period, it may face further financial challenges and diminished market presence.
Overall, Wall Street has a Strong Buy consensus rating on ALXO stock based on 3 Buys and 1 Hold.
To learn more about Alx Oncology Holdings, Inc.’s risk factors, click here.